Figure 2.
Growth of Caki‐1 cells following everolimus (A), sunitinib (B), or everolimus + sunitinib treatment (C). Cell growth was inhibited with 1 nmol/L everolimus or 0.5 μmol/L sunitinib as well as by 0.5 nmol/L everolimus +0.1 μmol/L sunitinib.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.